These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Establishment and characterization of a new Ph1-positive ALL cell line (ALL/MIK) presenting bcr gene rearrangement on bcr-2 and ALL-type bcr/abl transcript: suggestion of in vitro differentiation to monocytoid lineage. Higa T; Okabe M; Kunieda Y; Kodama S; Itaya T; Kurosawa M; Sakurada K; Maekawa I; Shoji M; Kasai M Leuk Lymphoma; 1994 Jan; 12(3-4):287-96. PubMed ID: 8167560 [TBL] [Abstract][Full Text] [Related]
9. [Analysis of breakpoints on BCR gene in acute leukemia patients with Ph1 chromosome]. Tanaka K; Takechi M; Shigeta C; Oguma N; Kamada N; Takimoto Y; Kuramoto A; Kyo T; Dohi H; Nakamura Y Rinsho Ketsueki; 1992 Jan; 33(1):1-10. PubMed ID: 1545509 [TBL] [Abstract][Full Text] [Related]
10. [Rearrangement and expression of bcr-abl genes in CML and ALL]. Kunieda Y; Okabe M Rinsho Ketsueki; 1991 Jun; 32(6):623-8. PubMed ID: 1890738 [TBL] [Abstract][Full Text] [Related]
11. [Cytogenetic and molecular aspects of Ph-positive leukemia]. Misawa S; Nishigaki H Rinsho Ketsueki; 1991 Apr; 32(4):313-8. PubMed ID: 2067072 [TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148). Beran M; Cao X; Estrov Z; Jeha S; Jin G; O'Brien S; Talpaz M; Arlinghaus RB; Lydon NB; Kantarjian H Clin Cancer Res; 1998 Jul; 4(7):1661-72. PubMed ID: 9676840 [TBL] [Abstract][Full Text] [Related]
13. Rearrangement of BCR genes in malignant lymphoma. Cheng G; McLeish W; Huebsch L; Drouin J; van der Jagt R; Tittley P; Markman S; Aye MT; Burns B Leukemia; 1992 Jun; 6(6):553-5. PubMed ID: 1602794 [TBL] [Abstract][Full Text] [Related]
15. Structural alterations of the BCR and ABL genes in Ph1 positive acute leukemias with rearrangements in the BCR gene first intron: further evidence implicating Alu sequences in the chromosome translocation. Chen SJ; Chen Z; Font MP; d'Auriol L; Larsen CJ; Berger R Nucleic Acids Res; 1989 Oct; 17(19):7631-42. PubMed ID: 2678002 [TBL] [Abstract][Full Text] [Related]
16. Studies of complex Ph translocations in cases with chronic myelogenous leukemia and one with acute lymphoblastic leukemia. Costa D; Carrió A; Madrigal I; Arias A; Valera A; Colomer D; Aguilar JL; Teixido M; Camós M; Cervantes F; Campo E Cancer Genet Cytogenet; 2006 Apr; 166(1):89-93. PubMed ID: 16616117 [TBL] [Abstract][Full Text] [Related]
17. Fusion of the bcr and the c-abl genes in Ph'-positive acute lymphocytic leukemia with no rearrangement in the breakpoint cluster region. ar-Rushdi A; Negrini M; Kurzrock R; Huebner K; Croce CM Oncogene; 1988 Apr; 2(4):353-7. PubMed ID: 3283653 [TBL] [Abstract][Full Text] [Related]
18. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973 [TBL] [Abstract][Full Text] [Related]
19. Consistent involvement of the 3' half part of the first BCR intron in adult Philadelphia-positive leukaemia without M-bcr rearrangement. Nakamura Y; Hirosawa S; Aoki N Br J Haematol; 1993 Jan; 83(1):53-7. PubMed ID: 8435337 [TBL] [Abstract][Full Text] [Related]
20. Bcr: a negative regulator of the Bcr-Abl oncoprotein. Wu Y; Ma G; Lu D; Lin F; Xu HJ; Liu J; Arlinghaus RB Oncogene; 1999 Aug; 18(31):4416-24. PubMed ID: 10442632 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]